Authors: Jade Parker, Editor
Find out all the latest headlines from the 11th European Breast Cancer Conference taking place in Barcelona, Spain (21–23rd March).
- Risk of a second breast cancer can be better quantified in women carrying a BRCA mutation
- Women with DCIS at lowest risk of recurrence if post-menopausal or have estrogen receptor positive cancer
- Screening helped reduce the average size of breast tumors decreased but size is now increasing again
Risk of a second breast cancer can be better quantified in women carrying a BRCA mutation
The risk of a second breast cancer in patients with high-risk BRCA gene mutations can be more precisely predicted by testing for several other genetic variants, each of which are known to have a small impact on breast cancer risk.